MiNK Therapeutics, Inc. (INKT)

USD 0.46

(-14.02%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - 2.7 Billion - - 689.62 Thousand
Cost of Revenue 204.61 Thousand 30.94 Billion 28.35 Billion 55.06 Thousand -
Gross Profit -204.61 Thousand -28.24 Billion -28.35 Billion -55.06 Thousand 689.62 Thousand
Operating Expenses 22.92 Million 30.94 Million 18.6 Million 10.79 Million 23.48 Million
Selling, General and Administrative Expenses 7.43 Million 7.83 Million 4.63 Million 1.28 Million 3.82 Million
Research and Development Expenses 15.48 Million 23.11 Million 13.96 Million 9.5 Million 19.65 Million
Other Expenses - 2.7 Million -9.53 Million -3 Million 551.23 Thousand
Cost and Expenses 22.92 Million 30.94 Million 18.6 Million 10.79 Million 23.48 Million
Operating Income -22.92 Million -30.94 Million -28.35 Million -14.63 Million -22.28 Million
Interest Expense - 253.32 Thousand 2.43 Million 2.44 Million 1.56 Million
Income Tax Expense - -3.21 Million -7.09 Million -560.38 Thousand 2.11 Million
Earnings before Tax -22.45 Million -27.99 Million -30.21 Million -16.23 Million -23.8 Million
Net Income -22.45 Million -24.77 Million -23.11 Million -15.67 Million -25.91 Million
Earnings Per Share Basic -0.65 -0.74 -0.69 -0.47 -0.78
Earnings Per Share Diluted -0.65 -0.74 -0.69 -0.47 -0.78
Weighted Average Shares Outstanding 34.35 Million 33.67 Million 33.47 Million 33.08 Million 33.08 Million
Weighted Average Shares Outstanding (Diluted) 34.35 Million 33.67 Million 33.47 Million 33.08 Million 33.08 Million
Gross Margin - -10.44 - - 1.00
EBIT Margin - -0.01 - - -32.20
Profit Margin - -0.01 - - -37.58
EBITDA -22.25 Million -30.82 Million -27.7 Million -13.74 Million -22.2 Million
Earnings Before Tax Margin - -0.01 - - -32.31

Income Statement Charts